Patients perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice
To the Editor,We read with great interest Megna et al. (1) article, as we concur that discontinuation of psoriatic drugs may lead to higher disease burden and health-related costs. As authors claim...
